Ignite Creation Date:
2024-05-05 @ 4:59 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00363090
Status:
UNKNOWN
Last Update Posted:
2013-09-20
First Post:
2006-08-10
Brief Title:
Alemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II Stage III or Stage IV T-Cell Non-Hodgkins Lymphoma
Sponsor:
Organization:
National Cancer Institute NCI